Skip to main content
Signal8

BIMI International Medical Inc. (BIMI)

BIMI International Medical Inc., headquartered in Chongqing, China, is an enterprise engaged in a diverse array of healthcare operations. The company, which was established in 2000 and adopted its current name in June 2021 (formerly BOQI International Medical Inc.), focuses on the supply and sale of medical devices, pharmaceuticals, and other health-related products. Its business activities are structured across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies. For its wholesale segment, BIMI distributes a wide range of specialized medical equipment, including Stryker spinal products, Olympus endoscopes, various imported imaging devices, and diagnostic imaging systems. These products are supplied to clients such as drugstores, private clinics, pharmaceutical dealers, and hospitals, particularly within China's Southwest region. The company also facilitates the distribution of a broad spectrum of pharmaceutical products, comprising generic medications, traditional Chinese herbal remedies, biochemical drugs, essential raw ingredients for pharmaceuticals, antibiotics, cardiovascular treatments, and anti-obesity medicines. Through its "Lijiantang Pharmacy" brand, BIMI operates a network of directly-owned retail outlets. These pharmacies offer consumers an extensive selection of items, including prescription and over-the-counter drugs, nutritional supplements, health foods, sundry goods, traditional Chinese medicines, personal and family care products, and medical devices. Beyond product sales, BIMI also delivers medical services within hospital environments and undertakes IT research and development initiatives.

Sector: Medical - Distribution

Industry: Medical - Distribution

BIMI International Medical Inc. logo

BIMI International Medical Inc.

OTC:BIMIHealthcare
CLOSED
Mkt Cap$6K
EV-
Float11.59M
O/S11.56M
VOL6K sh
$ Vol$1
RVOL2.73×
Inst Own-
SI0.4%
Net Cash/Sh-
Dilution
Short interest (FINRA)
0.4%
Oct 30 (18d)

Float 11.59M · FMP free float

41.4K
Oct 30 (18d)prev 41.5K▼ 0.2%
311.50
Oct 30 (18d)prev 28.50▲ 993.0%
Borrow (IBKR)

The cost to borrow BIMI shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
14
Jun 23 (147d)
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 202641.4K sh
Oct 15, 202641.5K sh
Sep 30, 202641.5K sh
Sep 15, 202641.5K sh
Aug 31, 202641.5K sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume

Too few published sessions to show a reading in context.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for BIMI: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 41,430 BIMI shares were sold short (0.36% of a 11.59M-share float, 311.50 days to cover).